Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Lydia Partners is a venture capital firm based in the United States, focusing on early-stage investments in healthcare, biotech, and consumer technology. They employ an operating venture model, collaborating closely with entrepreneurs to develop technologies that improve health and quality of life. The firm targets pre-seed to seed+ stages, with a portfolio that includes two notable companies.
Lydia Partners invests in early-stage companies within the healthcare and wellness sectors, specifically targeting innovative technologies. Their investment strategy emphasizes collaboration with creative entrepreneurs, aiming to revolutionize industries through technology. Typical investments occur at the pre-seed and seed stages, with a focus on consumer health and biomedical advancements.
Notable portfolio companies include OxeFit, a performance training system designed to enhance rehabilitation and strength-building for athletes, and Allied BioScience, which focuses on combating infectious diseases through antimicrobial technology.
Submit your pitch through their website's contact form for consideration. Be sure to include a detailed overview of your technology and its impact on consumer health.
Yes, Lydia Partners often leads investment rounds, particularly in the pre-seed and seed stages, to provide strong support for their portfolio companies.
The firm is open to follow-on investments, especially if the company demonstrates significant growth and aligns with their investment thesis in healthcare and consumer technology.
Specific fund size details are not disclosed, but Lydia Partners focuses on early-stage investments, indicating a targeted approach to funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.